Have you ever thought about taking part in a Medical Trial? By registering your details with MedTrials.co.uk, we are able to send your details directly to companies who are looking for volunteers to take part in their medical research studies.
Information about you is kept on a register that CROs, Pharmaceutical companies and Clinical Investigators can access to contact you regarding individual studies.
MedTrials.co.uk is a website that will put you in direct contact with Pharmaceutical Companies, CRO’s (Clinical Research Organisations) and Clinical Investigators that are running Phase I (1) and Phase II (2) clinical trials.
Medical trials are an integral part of the drug development process. Patient and volunteer participation is vital for continued medical research and these trials are carried out under strict regulations.
If at any point you feel that you have changed your mind and are no longer interested in undertaking a medical trial you can unsubscribe from our service. If you are already part way through a medical trial, speak to the Clinical Investigator and they will advise you of your options.
Clinical research companies often offer financial compensation for your time and expenses.
Migraines often involve heightened sensitivity to light. In a project funded by the Austrian Science Fund FWF, a team of researchers from the Medical University of Vienna is investigating new… Go to Source
An investigation published by The BMJ today raises new concerns about the top-selling anti-clotting drug, rivaroxaban (Xarelto). Go to Source
In a paper published in the current issue of Psychotherapy and Psychosomatics, Giovanni A. Go to Source
Past research has linked benzodiazepines – drugs used to treat anxiety and insomnia – to increased dementia risk for seniors, but a new study has found no such association. Go to Source
Researchers all over Europe are working on alternatives to animal testing that can be used to evaluate the adverse side-effects of medications. But many of these test methods still present problems. Go to Source
Sanofi, Diabetes UK and JDRF have announced the publication of IMPACT 2 in the journal Diabetic Medicine. Go to Source